Oxxon Therapeutics Inc.
2nd Floor Florey House<br>3 Robert Robinson Avenue
Oxford Science Park
Oxford
OX4 4GP
United Kingdom
Tel: 44-0-1865-398100
Fax: 44-0-1865-398101
Website: http://www.oxti.com/
Email: info@oxti.com
9 articles about Oxxon Therapeutics Inc.
-
Oxxon Therapeutics Inc. Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
1/21/2010
-
Oxxon Therapeutics Inc. to be Acquired by Oxford BioMedica PLC for GBP 16 Million
3/12/2007
-
Oxxon Therapeutics Inc.' Hi-8(TM) MEL Therapeutic Vaccine Demonstrates Potential For Treatment Of Advanced Metastatic Melanoma
6/6/2006
-
Oxxon Therapeutics Inc. To Present Phase IIA Survival Data For Its HI-8(TM) Mel Therapeutic Vaccine As A Treatment For Advanced Metastatic Melanoma
5/30/2006
-
Oxxon Therapeutics Inc. HI-8(TM) HBV Therapeutic Vaccine Proves Safe And Efficacious In Treating Chronic Hepatitis B
4/27/2006
-
Oxxon Therapeutics Inc. Appoints Craig R. Smith, M.D. Chairman And John Berriman Executive Deputy Chairman Of Its Board Of Directors
4/11/2006
-
Oxxon Therapeutics Inc. Reports Positive Preliminary Phase IIa Data With Chronic Hepatitis B Therapeutic Vaccine
11/11/2005
-
Oxxon Therapeutics Ltd Launches U.S. Operation And Announces New Name
4/13/2004
-
US Patent Establishes Oxxon Pharmaccines Ltd.'s Leadership Position In Prime Boost Technology
1/15/2004